Trading & Technical Analysis

A sizzling summer for stocks

Australian share markets have had a roaring start to 2020, with sizeable gains driven by momentum stocks, especially in IT and healthcare. Yet while companies like CSL are undoubtedly impressive, a closer inspection reveals some troubling nuances to the growth story, calling into question the high expectations imposed by a growth-starved market. It wasn’t just…

Federal Reserves Risky Q4 Stock Ramp

The US stock markets dramatically surged mostly in a straight line since mid-October. This extraordinary rally started when the Federal Reserve announced it would resume expanding its balance sheet for the first time in years. The deluge of new liquidity from that quantitative-easing bond buying has again acted like rocket fuel for stock markets. After…

IPOs Have Something for Everyone

In theory, investors considering an investment in an Initial Public Offering (IPO) should follow many of the same principles that apply to picking winning stocks already trading in public markets. In practice, the “must read” information contained in the IPO Prospectus published by about to list companies can be challenging to interpret. In August of…

Did BlackRock Pull the Plug on King Coal?

While coal has lost its grip on the title of “King of Commodities”, it has defied the oddsmakers predicting its ultimate demise. Numerous “King Coal is Dead” articles and contrarian views touting coal’s resilience litter the financial news. Yet the King stubbornly hangs on, defying the skeptics and delighting the contrarians. The “king coal is…

Gold Mining Stocks Are Wavering

The gold miners’ stocks are wavering, frustrating traders. For the better part of a half-year, this sector has neither broken out nor broken down. Instead it has mostly ground sideways since the last upleg’s peak. Gold stocks being mired in a consolidation so long, even a relatively-high one, is steadily eroding bullish sentiment. That ups…

Technology is reshaping modern medicine

But ethical and economic challenges could limit the benefits medtech brings to healthcare. The Nobel Prize in Medicine 2019 was awarded to three men for “their discoveries of how cells sense and adapt to oxygen availability”. The Nobel Prize in Medicine 2018 was given to two men “for their discovery of cancer therapy by inhibition…

Investor Signposts: Week Beginning January 20 2020

Australia: Quiet week ahead • The fourth week of the year looks to be a quiet one for economic data, both in Australia and the US. In Australia consumer sentiment and employment data dominate the list of scheduled releases. • The week kicks off on Tuesday when the Commonwealth Bank releases the December Household spending…

Gold buying surges can be precarious

Gold dramatically surged to major new secular highs this past week, fueled by stunning geopolitical news. The US assassinated Iran’s top general, so Iran fired ballistic missiles at military bases in Iraq used by the US. That naturally ramped gold bullishness, spawning all kinds of predictions for much-higher prices. But geopolitically-driven gold spikes never last…

Can these Worst Performers of 2019 Make a Comeback in 2020?

Regardless of investing philosophy, retail investors who pick their own stocks have much to consider reviewing the share price performance of annual “winners and losers” Growth investors who believe in buying high and selling higher gravitate towards the year’s best performers. Momentum and value investors can consider select losers capable of a comeback or a…

Beware The Downside Of Gold Stocks

The gold miners’ stocks have largely been consolidating high following last summer’s powerful upleg. That resilience has left sentiment relatively bullish, with traders mostly expecting this sector to soon start surging again. But the jury is still out on whether gold stocks will be lucky enough to evade a bigger correction. Major downside risks still…